News - Sanofi


Current filters:


Popular Filters

170 to 194 of 311 results

FDA advisory panel votes 9 to 6 to approve Genzyme's Kynamro


The US Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory yesterday voted by…

BiotechnologyCardio-vascularGenzymeIsis PharmaceuticalsKynamroNorth AmericaPharmaceuticalRare diseasesRegulationSanofi

US FDA agrees to review Sanofi Pasteur's new quadrivalent influenza vaccine


Sanofi Pasteur, the vaccines division of Sanofi (Euronext: SAN) says it has filed a supplemental Biologics…

Anti-viralsNorth AmericaPharmaceuticalRegulationSanofiSanofi PasteurVaccines

Highlights from ECTRIMS include new data for Gilenya, Sativex and Aubagio


New data presented at the 28th congress of the European Committee for Treatment and Research in Multiple…

AlmirallAubagioBiotechnologyGenzymeGilenyaGW PharmaceuticalsNeurologicalNovartisPharmaceuticalResearchSanofiSativex

Watson gets FDA approval for generic Sanctura XR and Avapro


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has received approval from the US Food and Drug…

AllerganAvaproCardio-vascularGenericsGenito-urinaryNorth AmericaRegulationSanctura XRSanofiWatson Pharmaceuticals

Positive Ph III VELOUR results with Sanofi's Zaltrap


French drug major Sanofi (Euronext: SAN) says that positive detailed results from the pivotal Phase III…


Sanofi links with Massachusetts General Hospital for oncology research


French drug major Sanofi (Euronext: SAN) has entered in to a two-year agreement with Massachusetts General…


News briefs: AstraZeneca suspends share repurchasing; New CMO for Sanofi; Research facility for Octapharma


Anglo-Swedish drug major AstraZeneca (LSE: AZN) saw its shares dip 1.8% to £29.02 in early afternoon…


Osiris regains worldwide rights to Prochymal and Chondrogen from Sanofi


As a result of the termination of its collaboration with Genzyme, a subsidiary of French drug major Sanofi…

BiotechnologyChondrogenGenzymeImmunologicalsInflammatory diseasesLicensingOsiris TherapeuticsPharmaceuticalProchymalSanofi

Sanofi to cut 900 French research posts, a lot fewer than had been feared


French drug major Sanofi (Euronext: SAN) yesterday fleshed out on its plans for changes in its research…


Pharma vs the world: Big Pharma caught between investors and public


Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

Analyst insight: Sanofi eyes Columbia, Indonesia and Vietnam


Emerging markets, BRIC countries are words that have recently risen to prominence in a majority of pharmaceutical…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalSanofiSouth America

Oncodesign in up to 130 million-euro deal with Sanofi


Oncodesign, a Dijon, France-based drug discovery company and oncology pharmacology service provider,…


FDA thumbs up for Sanofi's MS drug Aubagio


As has been largely expected, the US Food and Drug Administration yesterday approved marketing of French…

AubagioBiotechnologyGenzymeNeurologicalNorth AmericaPharmaceuticalRegulationSanofi

Clinical trial results indicate advance in Dengue vaccine research by Sanofi Pasteur


The Dengue Vaccine Initiative (DVI) has welcomed new clinical trial results that reveal progress in developing…

CYD-TDVSanofiSanofi Pasteur

Impax Labs settles with Genzyme over Renvela and Renagel generics


USA-based Impax Laboratories (Nasdaq: IPXL) says it has reached agreement with French drug major Sanofi's…

GenzymeImpax LaboratoriesPatentsPharmaceuticalRenagelRenvelaSanofi

New Zealand's PHARMAC agrees pricing deal with Sanofi for Arava


New Zealand's national pharmaceuticals funding agency, PHARMAC, has announced changes to the listings…


Teva launches generic Aprovel in UK


The UK subsidiary of Israel's Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic…

AprovelBristol-Myers SquibbCardio-vascularEuropeGenericsMarkets & MarketingSanofiTeva Pharmaceutical Industries

FDA calls on Genzyme to re-file Lemtrada sBLA


French drug major Sanofi (Euronext: SAN) revealed yesterday that its US biotech subsidiary has received…

BayerBiotechnologyGenzymeLemtradaNeurologicalNorth AmericaPharmaceuticalRegulationSanofi

Anti-clotting drugs prasugrel and clopidogrel yield similar results


The TRILOGY ACS study, the first trial to study patients with acute coronary syndrome who do not undergo…

Bristol-Myers SquibbCardio-vascularDaiichi SankyoEffientEli LillyPharmaceuticalPlavixResearchSanofi

170 to 194 of 311 results

Back to top